Sorafenib for Research

99% Pure; VEGFR-2 & PDGFR Inhibitor 100 mg $98; 300 mg $225 - Bulk Also (Sponsored Link)
http://www.LCLabs.com/

 

FDA Approves Sorafenib (Nexavar)

FDA Home Page | CDER Home Page | CDER Site Info | / Contact CDER | ... Diarrhea was reported in 55% of sorafenib patients (grade 3 in 10%). ... Treatment-emergent hypertension was reported in 9% of...
http://www.fda.gov/CDER/Offices/OODP/whatsnew/sorafenib.htm

 

Sorafenib (Nexavar®) : Cancerbackup

... Sorafenib is also called Nexavar®. ... What is sorafenib? ... What is sorafenib? ... Sorafenib blocks the activity of VEGF. ...
http://www.cancerbackup.org.uk/Treatments/Biologicaltherapies/Cancergrowthinhibitors/Sorafenib

 

Nexavar (sorafenib)

Search: All NetDoctor ... Advanced kidney cancer Sorafenib tosylate. ... Sorafenib works by inhibiting the action of various kinase enzymes. ... Sorafenib is licensed to treat...
http://www.netdoctor.co.uk/medicines/100005116.html

 

Sorafenib - Wikipedia

Sorafenib ... Sorafenib (marketed as Nexavar by Bayer) is a drug used for the treatment of advanced renal cell cancer. ... In a large, phase III study, sorafenib showed improved...
http://en.wikipedia.org/wiki/Sorafenib

 

Sorafenib for hepatocellular carcinoma (HCC) - NeLM

About the NeLM | / Help & Support | / Site Feedback | / Update Newsletter Subscription / Homepage / Login | / Register / Search the NeLM ... The effect of sorafenib in HCC patients with a poorer prognosis has not been...
http://www.nelm.nhs.uk/en/NeLM-Area/Evidence/Drug-Specific-Reviews/Sorafenib-for-hepatocellular-carcinoma-HCC/

 

CancerGuide: BAY 43-9006 (Sorafenib)

Home | / What's New | / About | / Contact | / Sitemap / CancerGuide: Special Kidney Cancer Section / About CancerGuide / Cancer Basics / Research Your Options / Clinical Trials / Specific Cancers / Kidney Cancer / • Kidney Cancer Home / • What's...
http://cancerguide.org/rcc_bay43-9006.html

 

Sorafenib in Myelodysplastic Syndrome

Home / Pharmaceutical Reports / Pharmaceutical report sourcer / DailyUpdates: Advances for Drug Development / Key Scientific Journal Articles / Submit your Research / Drug Development News / New Clinical Trials / Pharmaceutical events / UpdatesPlus...
http://www.leaddiscovery.co.uk/trials/997/

 

SORAFENIB FOR THE TREATMENT OF RENAL CELL CARCINOMA

... An evaluation of the research exploring sorafenib as a potential therapy for RCC was conducted. ... Sorafenib received FDA approval in December 2005 for treatment of advanced RCC. CONCLUSIONS:...
http://www.jpharmtechnol.com/abstracts/volume22/September-October/281.html

 

HON - News : Sorafenib Slows Growth of Some Leukemias

What is it? Speech: / HONcode sites All Web sites HONselect News Conferences Images / Themes: / A B C D E F G H I / J K L M N O P Q ... Sorafenib slowed growth and induced cell death in the FLT3 mutant leukemia cells and...
http://www.hon.ch/News/HSN/612146.html

 

The ability of sorafenib to inhibit oncogenic PDGF...[Haematologica. 2007] - PubMed Result

NCBI ... Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia. ... Antitumor activity of sorafenib in FLT3-driven leukemic cells. ... Sorafenib is in a class...
http://www.ncbi.nlm.nih.gov/pubmed/17229632/

 
1 | 2 | 3 | 4 | 5 | 6 | 7 | >